Browse the evidence

A 76-protein plasma proteomic signature of age (PROage) and its derived measure of biological age acceleration (PROaccel) predict the accumulation of chronic diseases (multimorbidity) and all-cause mortality independent of chronological age.

Your chronological age is not your destiny. This research identifies a specific set of 76 proteins in your blood that act as a 'biological clock.' If your biological age (calculated from these proteins) is higher than your actual age, you are at significantly higher risk for developing multiple chronic diseases and dying earlier. This test can identify 'fast-agers' who may benefit from early, intensive lifestyle or medical interventions to slow down this biological acceleration, rather than waiting for symptoms to appear.

Activation of adenosine A1 receptors (AdoA1R) is required to generate the homeostatic rebound in slow-wave activity (SWA) following sleep restriction, and this specific SWA rebound is necessary to maintain normal working memory performance under sleep-deprived conditions.

To maintain cognitive performance during periods of sleep restriction, your brain needs to generate a strong 'slow-wave activity' (SWA) rebound. This process is driven by adenosine acting on A1 receptors. While caffeine blocks these receptors and reduces SWA (potentially impairing recovery), ensuring adequate adenosine signaling (e.g., through natural sleep pressure without excessive caffeine interference) may support the cognitive benefits of sleep. Prioritize sleep quality and depth over mere duration when recovering from sleep loss.

Metabolic health is determined by the capacity of adipose tissue to expand (adipose expandability) rather than absolute fat mass; when this capacity is exceeded, ectopic fat accumulation and insulin resistance occur.

Focus on maintaining healthy fat distribution and avoiding excessive caloric overload that exceeds your body's ability to store fat safely, rather than solely targeting weight loss numbers.

Subcutaneous fat, particularly in the limbs and gluteal regions, plays a protective metabolic role by safely storing lipids, whereas visceral fat accumulation is strongly associated with metabolic complications.

Preserve subcutaneous fat in limbs and glutes if possible, as it protects against metabolic disease, while minimizing visceral fat accumulation.

Antidiabetic drugs like metformin and liraglutide exert part of their beneficial effects by modifying gut microbiota composition, specifically by increasing the abundance of Akkermansia muciniphila.

If you are taking metformin or liraglutide, part of their benefit may come from how they change your gut bacteria. This highlights the importance of gut health in diabetes management, even when using medication.

Obesity-induced chronic inflammation in adipose tissue, driven by M1 macrophage infiltration and TNFα secretion, directly causes systemic insulin resistance.

In obesity, fat tissue becomes inflamed, releasing chemicals like TNFα that block insulin action. This inflammation is a key driver of insulin resistance, not just excess calories. Strategies that reduce this specific inflammatory response may help improve metabolic health.

MCP-1 (CCL2) secretion from hypertrophied adipocytes recruits monocytes to adipose tissue, leading to M1 macrophage infiltration and insulin resistance.

High levels of MCP-1 in fat tissue act as a beacon, pulling inflammatory cells into fat. Reducing MCP-1 levels might help prevent this inflammatory infiltration.

Middle-aged men with metabolic syndrome (defined by NCEP or WHO criteria) have a significantly increased risk of all strokes and ischemic strokes, independent of other known cardiovascular risk factors.

If you are a middle-aged man, getting your metabolic health checked is critical for stroke prevention. This means monitoring blood pressure, blood sugar, cholesterol, and waist size together. If you meet the criteria for metabolic syndrome, you have roughly double the risk of stroke compared to those who don't, even if you don't smoke or have high cholesterol. Addressing the cluster of issues is more important than treating just one.

Shorter sleep duration (measured objectively via actigraphy) is associated with a lower secondary antibody response to the hepatitis B vaccine and a decreased likelihood of achieving clinical protection (anti-HBs IgG ≥ 10 mIU/ml).

If you are getting a vaccine, prioritize getting enough total hours of sleep in the days leading up to and following the shot. Objective sleep duration matters more for your immune response than how efficiently you sleep or how good you feel you slept. Aim for longer sleep duration (e.g., >7 hours) to maximize your antibody protection.

Knockdown of the autophagy-related gene Atg14 in the liver leads to elevated hepatic and serum triglyceride levels, indicating that Atg14-mediated autophagy is critical for maintaining lipid homeostasis.

This research highlights that your liver's ability to break down fat (lipophagy) is regulated by specific genes (like Atg14) that respond to your body's internal clock and nutrient status. While this is a mouse study, it suggests that maintaining healthy circadian rhythms and avoiding constant nutrient overload may support your liver's natural fat-processing mechanisms.

Overexpression of Atg14 improves hypertriglyceridemia in high-fat diet-treated mice and FoxO-deficient mice by enhancing hepatic autophagy.

This study suggests that boosting liver autophagy genes might help manage high fat levels in the blood, especially when diet or genetics impair normal fat processing. For humans, this underscores the potential value of lifestyle factors that naturally support cellular cleanup processes, such as intermittent fasting or regular exercise.

Inhibition of soluble epoxide hydrolase (sEH) using the inhibitor t-TUCB increases tissue levels of omega-3 epoxides (17,18-EEQ and 19,20-EDP), which reduces inflammation, restores autophagy, and attenuates endoplasmic reticulum stress in obese adipose tissue and liver.

This research suggests that simply consuming omega-3 fatty acids might not be enough for optimal metabolic health in obesity. The body converts these fats into powerful signaling molecules called epoxides, which are normally broken down quickly by an enzyme called sEH. Inhibiting this enzyme (as done with t-TUCB in this study) allows these beneficial signals to persist, reducing liver fat and inflammation. While this specific drug is not a consumer supplement, it highlights the importance of the metabolic pathway of omega-3s and suggests that strategies preserving these epoxides could be therapeutic for metabolic disorders.

Pharmacological re-activation of AMPK in the liver suppresses hepatic steatosis by inhibiting lipid synthesis and stimulating fatty acid oxidation, whereas genetic loss of AMPK does not cause fatty liver development.

While low AMPK activity is linked to fatty liver, simply having low activity doesn't cause the fat accumulation. However, drugs that activate AMPK (like metformin or specific activators) can help reduce liver fat by blocking fat creation and increasing fat burning. This suggests that targeting AMPK is a valid treatment strategy for fatty liver, even if low AMPK itself isn't the initial cause.

Aging is characterized by a significant decline in adaptive homeostasis capacity, specifically the inability to transiently expand or contract homeostatic ranges in response to sub-toxic stressors, leading to increased susceptibility to damage and mortality.

As you age, your body's ability to bounce back from minor stressors (like mild exercise or dietary changes) diminishes. This isn't just about damage accumulation; it's about losing the signaling capacity to adapt. To maintain healthspan, focus on avoiding chronic, repetitive stressors rather than seeking constant 'hormetic' spikes, as your adaptive reserves are likely compressed.

Adipocyte-specific deletion of the NAD+-biosynthetic enzyme NAMPT causes multi-organ insulin resistance and adipose tissue dysfunction, which is reversed by administering the NAD+ precursor nicotinamide mononucleotide (NMN).

This research suggests that maintaining healthy NAD+ levels in fat tissue is crucial for preventing insulin resistance, even if you are not overweight. While this study used mice, it highlights that metabolic health is tissue-specific. For humans, this supports the broader interest in NAD+ precursors (like NMN) and lifestyle factors (like caloric restriction) that naturally boost adipose NAD+ levels, rather than focusing solely on weight loss.

IGF-1 and insulin signaling are critical for suppressing FoxO-mediated protein degradation, and their reduction contributes to muscle atrophy by releasing FoxO inhibition.

Maintaining healthy insulin and IGF-1 levels is crucial for preventing muscle loss. These hormones not only stimulate muscle growth but also actively suppress muscle breakdown pathways. A balanced diet that supports healthy insulin sensitivity is essential for muscle preservation.

Using alternative methods to account for dietary misreporting (specifically revised Goldberg and predicted total energy expenditure methods) strengthens and clarifies the associations between dietary intake and body mass index compared to the original Goldberg method.

When analyzing diet and weight data, do not rely solely on standard energy reporting cutoffs. Use alternative methods like predicted total energy expenditure (pTEE) or revised basal metabolic rate equations to identify and account for misreporting. This approach strengthens the observed associations between diet and BMI, providing more accurate insights into how specific foods impact weight.

Early aggressive provision of full caloric and protein targets in critically ill patients provides no clinical benefit and may cause harm, whereas permissive underfeeding (restricted feeding) during the acute phase reduces ICU-acquired weakness and improves outcomes.

In the first week of critical illness, do not aim to meet full caloric or protein targets. Instead, use a 'permissive underfeeding' strategy. This approach has been shown to reduce muscle weakness and improve recovery compared to aggressive feeding. Focus on safety and tolerance rather than hitting specific calorie numbers immediately.

Immune-modulating nutrition (supplementation with glutamine, arginine, omega-3 fatty acids, and antioxidants) does not improve outcomes in general critically ill patients and may increase mortality, although it may benefit specific subgroups like severe burn patients.

Do not routinely use immune-modulating supplements (glutamine, arginine, omega-3s) for general critically ill patients. These supplements have been shown to increase mortality or provide no benefit in large trials. They may be considered for specific subgroups like severe burn patients, but this requires specialist judgment.

Bariatric surgery (RYGB and SG) induces sustained weight loss and metabolic improvements through hormonal and neural mechanisms (increased GLP-1/PYY, decreased ghrelin, altered bile acids) rather than solely through caloric restriction or malabsorption.

For patients with severe obesity, bariatric surgery (RYGB or SG) is the most effective treatment for sustained weight loss and metabolic health. The success is largely due to hormonal changes (increased GLP-1/PYY, decreased ghrelin) that reduce hunger and improve glucose control, rather than just eating less. This suggests that non-surgical treatments targeting these same hormones (like GLP-1 agonists) may be effective alternatives for some.

Overexpression of SIRT1 in skeletal muscle inhibits muscle atrophy during fasting and denervation by deacetylating and blocking the activity of transcription factors FoxO1 and FoxO3, thereby suppressing the expression of atrogenes (atrogin1, MuRF1) and autophagy genes.

This research identifies SIRT1 as a key protector against muscle loss during starvation or nerve damage. While this paper uses genetic overexpression in mice, it suggests that boosting SIRT1 activity (potentially through lifestyle or future drugs) could prevent muscle wasting. For now, maintaining healthy SIRT1 levels through exercise and metabolic health may support muscle preservation.

SIRT1 overexpression induces rapid muscle hypertrophy in fed, normal mice without activating the PI3K-AKT signaling pathway.

SIRT1 can promote muscle growth through a unique mechanism that bypasses the usual growth signals (like insulin/IGF-1). This suggests that metabolic health and SIRT1 activity are crucial for maintaining muscle size, independent of traditional strength training signals.

High-fat diet feeding induces an early and sustained infiltration of pro-inflammatory macrophages (CD11c+CD11b+F4/80+) into skeletal muscle, which correlates with insulin resistance and is dependent on the chemokine CCL2.

In the context of obesity and high-fat diets, skeletal muscle undergoes a specific immune response where pro-inflammatory macrophages infiltrate the tissue, driven by the chemokine CCL2. This infiltration is directly linked to the development of insulin resistance. While this is a mechanistic finding primarily from mouse models, it suggests that chronic high-fat intake triggers a local immune response in muscle that impairs glucose disposal, independent of simple caloric excess.

Young men with newly diagnosed fatty liver exhibit impaired left ventricular energy metabolism (reduced PCr/ATP ratio) and increased mediastinal fat, despite having normal left ventricular morphology and systolic/diastolic function.

If you have been diagnosed with fatty liver, even if you are young, fit, and have normal blood pressure and standard heart function tests, your heart's energy efficiency may already be compromised. This metabolic shift happens before your heart shows signs of failure on standard exams. Addressing the underlying metabolic drivers (like insulin resistance and visceral fat) is critical to prevent long-term cardiac remodeling.